Whittier Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Whittier Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85	Closed	-$11K	–	1590
2023 Q3	$11K	Buy	85 +5	+6%	+$666	﹤0.01%	1245
2023 Q2	$9.92K	Buy	+80	New	+$10.8K	﹤0.01%	1273
2022 Q4	–	Sell	-8	Closed	-$1K	–	1665
2022 Q3	$1K	Hold	8	–	–	﹤0.01%	1606
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	1618
2022 Q1	$1K	Buy	+8	New	+$1.16K	﹤0.01%	1642
2020 Q1	–	Sell	-18	Closed	-$3K	–	1532
2019 Q4	$3K	Hold	18	–	–	﹤0.01%	1312
2019 Q3	$2K	Hold	18	–	–	﹤0.01%	1377
2019 Q2	$3K	Hold	18	–	–	﹤0.01%	1193
2019 Q1	$3K	Buy	18 +8	+80%	+$1.04K	﹤0.01%	1174
2018 Q4	$1K	Hold	10	–	–	﹤0.01%	1282
2018 Q3	$2K	Hold	10	–	–	﹤0.01%	1189
2018 Q2	$2K	Hold	10	–	–	﹤0.01%	1172
2018 Q1	$2K	Hold	10	–	–	﹤0.01%	1214
2017 Q4	$1K	Hold	10	–	–	﹤0.01%	1232
2017 Q3	$1K	Buy	+10	New	+$1.51K	﹤0.01%	1271
2017 Q1	–	Sell	-4,450	Closed	-$485K	–	1364
2016 Q4	$485K	Hold	4,450	–	–	0.02%	343
2016 Q3	$541K	Hold	4,450	–	–	0.02%	333
2016 Q2	$629K	Hold	4,450	–	–	0.03%	317
2016 Q1	$581K	Hold	4,450	–	–	0.03%	326
2015 Q4	$625K	Buy	+4,450	New	+$617K	0.03%	325
2015 Q2	–	Sell	-156	Closed	-$27K	–	1248
2015 Q1	$27K	Buy	+156	New	+$26.8K	﹤0.01%	823

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Whittier Trust's JAZZ Position: Q4 2023 in Review

Whittier Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 85 shares — an estimated $11K sold.

Whittier Trust first reported a position in JAZZ in Q1 2015 and held it in 21 quarters. The position peaked at $629K in Q2 2016. 500 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

Whittier Trust reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Whittier Trust sold 85 Jazz Pharmaceuticals shares in Q4 2023, an estimated $11K.
Whittier Trust first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 21 quarters.
Whittier Trust's Jazz Pharmaceuticals position peaked at $629K in Q2 2016.
500 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Whittier Trust's 13F filing for Q4 2023, filed 11 Jan 2024.